| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A collaborative approach to headache classification
|
The Lancet Neurology,
|
|
2013
|
12 |
8 |
p. 727-
1 p.
|
artikel
|
| 2 |
Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome
|
Hagerman, Randi
|
|
2013
|
12 |
8 |
p. 786-798
13 p.
|
artikel
|
| 3 |
Corrections
|
|
|
2013
|
12 |
8 |
p. 733-
1 p.
|
artikel
|
| 4 |
Developmental topographical disorientation: lost every day
|
Iaria, Giuseppe
|
|
2013
|
12 |
8 |
p. 745-
1 p.
|
artikel
|
| 5 |
Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial
|
|
|
2013
|
12 |
8 |
p. 768-776
9 p.
|
artikel
|
| 6 |
Efficient use of MRI for dose finding in multiple sclerosis
|
Barkhof, Frederik
|
|
2013
|
12 |
8 |
p. 730-731
2 p.
|
artikel
|
| 7 |
Europe to take up brain disorders challenge
|
Quaglio, Gianluca
|
|
2013
|
12 |
8 |
p. 737-738
2 p.
|
artikel
|
| 8 |
Is it better to know?
|
Goodrick, Steven
|
|
2013
|
12 |
8 |
p. 744-
1 p.
|
artikel
|
| 9 |
Matthias Koepp
|
|
|
2013
|
12 |
8 |
p. 742-
1 p.
|
artikel
|
| 10 |
May, 2013
|
|
|
2013
|
12 |
8 |
p. 742-
1 p.
|
artikel
|
| 11 |
Microbleeds in cerebral small vessel disease
|
Braun, Holger
|
|
2013
|
12 |
8 |
p. 735-736
2 p.
|
artikel
|
| 12 |
Microbleeds in cerebral small vessel disease – Authors' reply
|
Wardlaw, Joanna
|
|
2013
|
12 |
8 |
p. 736-737
2 p.
|
artikel
|
| 13 |
Neural tube defects: recent advances, unsolved questions, and controversies
|
Copp, Andrew J
|
|
2013
|
12 |
8 |
p. 799-810
12 p.
|
artikel
|
| 14 |
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|
Wardlaw, Joanna M
|
|
2013
|
12 |
8 |
p. 822-838
17 p.
|
artikel
|
| 15 |
Neuroscience takes centre stage
|
Ranscombe, Peter
|
|
2013
|
12 |
8 |
p. 743-
1 p.
|
artikel
|
| 16 |
New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease
|
Calabresi, Paolo
|
|
2013
|
12 |
8 |
p. 811-821
11 p.
|
artikel
|
| 17 |
News in brief
|
|
|
2013
|
12 |
8 |
p. 746-
1 p.
|
artikel
|
| 18 |
Paolo Calabresi: the supremo of synaptic plasticity
|
Holmes, David
|
|
2013
|
12 |
8 |
p. 741-
1 p.
|
artikel
|
| 19 |
P-glycoprotein expression and antiepileptic drug resistance
|
French, Jacqueline A
|
|
2013
|
12 |
8 |
p. 732-733
2 p.
|
artikel
|
| 20 |
P-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control study
|
Feldmann, Maria
|
|
2013
|
12 |
8 |
p. 777-785
9 p.
|
artikel
|
| 21 |
Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial
|
Schapira, Anthony HV
|
|
2013
|
12 |
8 |
p. 747-755
9 p.
|
artikel
|
| 22 |
PROUD stands tall: delayed-start studies in Parkinson's disease
|
Hauser, Robert A
|
|
2013
|
12 |
8 |
p. 728-729
2 p.
|
artikel
|
| 23 |
Restless legs syndrome and cerebrovascular disease
|
Sechi, GianPietro
|
|
2013
|
12 |
8 |
p. 734-
1 p.
|
artikel
|
| 24 |
Restless legs syndrome and cerebrovascular disease – Authors' reply
|
Mehanna, Raja
|
|
2013
|
12 |
8 |
p. 734-735
2 p.
|
artikel
|
| 25 |
Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study
|
Selmaj, Krzysztof
|
|
2013
|
12 |
8 |
p. 756-767
12 p.
|
artikel
|
| 26 |
The Harvard Biomarker Study's big plan
|
Mohammadi, Dara
|
|
2013
|
12 |
8 |
p. 739-740
2 p.
|
artikel
|
| 27 |
Three decades of caring for the Venezuelan Huntington's disease families
|
Wexler, Nancy S
|
|
2013
|
12 |
8 |
p. 738-
1 p.
|
artikel
|
| 28 |
Thrombolysis with alteplase after stroke: extending outcomes
|
Anderson, Craig
|
|
2013
|
12 |
8 |
p. 731-732
2 p.
|
artikel
|
Tijdschrift beschrijving